Favourable Signals For Rani Therapeutics Holdings: Numerous Insiders Acquired Stock [Yahoo! Finance]
BGC, DRS and AMTX are among after hour movers [Seeking Alpha]
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $21.00 to $9.00. They now have a "buy" rating on the stock.
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its price target lowered by analysts at HC Wainwright from $16.00 to $12.00. They now have a "buy" rating on the stock.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript [Yahoo! Finance]